ID   ODPB_HUMAN              Reviewed;         359 AA.
AC   P11177; B2R7L0; B4DDD7; Q6FH45; Q9BQ27; Q9UFK3;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   06-MAR-2007, sequence version 3.
DT   12-APR-2017, entry version 202.
DE   RecName: Full=Pyruvate dehydrogenase E1 component subunit beta, mitochondrial;
DE            Short=PDHE1-B;
DE            EC=1.2.4.1;
DE   Flags: Precursor;
GN   Name=PDHB; Synonyms=PHE1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2323578; DOI=10.1016/0378-1119(90)90294-2;
RA   Ho L., Patel M.S.;
RT   "Cloning and cDNA sequence of the beta-subunit component of human
RT   pyruvate dehydrogenase complex.";
RL   Gene 86:297-302(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1702713; DOI=10.1111/j.1432-1033.1990.tb15656.x;
RA   Chun K., MacKay N., Willard H.F., Robinson B.H.;
RT   "Isolation, characterization and chromosomal localization of cDNA
RT   clones for the E1 beta subunit of the pyruvate dehydrogenase
RT   complex.";
RL   Eur. J. Biochem. 194:587-592(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-31.
RX   PubMed=2376596;
RA   Huh T.L., Casazza J.P., Huh J.W., Chi Y.T., Song B.J.;
RT   "Characterization of two cDNA clones for pyruvate dehydrogenase E1
RT   beta subunit and its regulation in tricarboxylic acid cycle-deficient
RT   fibroblast.";
RL   J. Biol. Chem. 265:13320-13326(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1).
RX   PubMed=2377599; DOI=10.1073/pnas.87.15.5594;
RA   Koike K., Urata Y., Koike M.;
RT   "Molecular cloning and characterization of human pyruvate
RT   dehydrogenase beta subunit gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:5594-5597(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT VAL-31.
RX   PubMed=3422424; DOI=10.1073/pnas.85.1.41;
RA   Koike K., Ohta S., Urata Y., Kagawa Y., Koike M.;
RT   "Cloning and sequencing of cDNAs encoding alpha and beta subunits of
RT   human pyruvate dehydrogenase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:41-45(1988).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11230166; DOI=10.1101/gr.GR1547R;
RA   Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S.,
RA   Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H.,
RA   Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N.,
RA   Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D.,
RA   Wambutt R., Korn B., Klein M., Poustka A.;
RT   "Towards a catalog of human genes and proteins: sequencing and
RT   analysis of 500 novel complete protein coding human cDNAs.";
RL   Genome Res. 11:422-435(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain cortex;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PRELIMINARY NUCLEOTIDE SEQUENCE [MRNA] OF 23-69.
RX   PubMed=2829898; DOI=10.1016/0006-291X(88)90714-0;
RA   Ho L., Javed A.A., Pepin R.A., Thekkumkara T.J., Raefsky C.,
RA   Mole J.E., Caliendo A.M., Kwon M.S., Kerr D.S., Patel M.S.;
RT   "Identification of a cDNA clone for the beta-subunit of the pyruvate
RT   dehydrogenase component of human pyruvate dehydrogenase complex.";
RL   Biochem. Biophys. Res. Commun. 150:904-908(1988).
RN   [13]
RP   PROTEIN SEQUENCE OF 31-43.
RC   TISSUE=Heart;
RX   PubMed=7895732; DOI=10.1002/elps.11501501209;
RA   Corbett J.M., Wheeler C.H., Baker C.S., Yacoub M.H., Dunn M.J.;
RT   "The human myocardial two-dimensional gel protein database: update
RT   1994.";
RL   Electrophoresis 15:1459-1465(1994).
RN   [14]
RP   PROTEIN SEQUENCE OF 31-55.
RX   PubMed=2295468; DOI=10.1002/hep.1840110105;
RA   Muno D., Kominami E., Ishii H., Usui K., Saifuku K., Sakakibara Y.,
RA   Namihisa T.;
RT   "Isolation of tryptic fragment of antigen from mitochondrial inner
RT   membrane proteins reacting with antimitochondrial antibody in sera of
RT   patients with primary biliary cirrhosis.";
RL   Hepatology 11:16-23(1990).
RN   [15]
RP   SUBUNIT.
RX   PubMed=14638692; DOI=10.1074/jbc.M308172200;
RA   Hiromasa Y., Fujisawa T., Aso Y., Roche T.E.;
RT   "Organization of the cores of the mammalian pyruvate dehydrogenase
RT   complex formed by E2 and E2 plus the E3-binding protein and their
RT   capacities to bind the E1 and E3 components.";
RL   J. Biol. Chem. 279:6921-6933(2004).
RN   [16]
RP   INTERACTION WITH DLAT, AND MUTAGENESIS OF GLU-259; GLU-262; GLU-264;
RP   ASP-319 AND ILE-359.
RX   PubMed=20160912; DOI=10.1016/j.molcatb.2009.05.001;
RA   Patel M.S., Korotchkina L.G., Sidhu S.;
RT   "Interaction of E1 and E3 components with the core proteins of the
RT   human pyruvate dehydrogenase complex.";
RL   J. Mol. Catal., B Enzym. 61:2-6(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 32-359 IN COMPLEX WITH
RP   THIAMINE PYROPHOSPHATE, AND COFACTOR.
RX   PubMed=12651851; DOI=10.1074/jbc.M300339200;
RA   Ciszak E.M., Korotchkina L.G., Dominiak P.M., Sidhu S., Patel M.S.;
RT   "Structural basis for flip-flop action of thiamin pyrophosphate-
RT   dependent enzymes revealed by human pyruvate dehydrogenase.";
RL   J. Biol. Chem. 278:21240-21246(2003).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF 32-359, SUBUNIT, AND
RP   FUNCTION.
RX   PubMed=17474719; DOI=10.1021/bi700083z;
RA   Seifert F., Ciszak E., Korotchkina L., Golbik R., Spinka M.,
RA   Dominiak P., Sidhu S., Brauer J., Patel M.S., Tittmann K.;
RT   "Phosphorylation of serine 264 impedes active site accessibility in
RT   the E1 component of the human pyruvate dehydrogenase multienzyme
RT   complex.";
RL   Biochemistry 46:6277-6287(2007).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) OF 31-359, CATALYTIC ACTIVITY,
RP   SUBUNIT, COFACTOR, AND FUNCTION.
RX   PubMed=19081061; DOI=10.1016/j.str.2008.10.010;
RA   Kato M., Wynn R.M., Chuang J.L., Tso S.C., Machius M., Li J.,
RA   Chuang D.T.;
RT   "Structural basis for inactivation of the human pyruvate dehydrogenase
RT   complex by phosphorylation: role of disordered phosphorylation
RT   loops.";
RL   Structure 16:1849-1859(2008).
RN   [23]
RP   VARIANTS PDHBD CYS-132 AND SER-344.
RX   PubMed=15138885; DOI=10.1007/s00439-004-1124-8;
RA   Brown R.M., Head R.A., Boubriak I.I., Leonard J.V., Thomas N.H.,
RA   Brown G.K.;
RT   "Mutations in the gene for the E1beta subunit: a novel cause of
RT   pyruvate dehydrogenase deficiency.";
RL   Hum. Genet. 115:123-127(2004).
CC   -!- FUNCTION: The pyruvate dehydrogenase complex catalyzes the overall
CC       conversion of pyruvate to acetyl-CoA and CO(2), and thereby links
CC       the glycolytic pathway to the tricarboxylic cycle.
CC       {ECO:0000269|PubMed:17474719, ECO:0000269|PubMed:19081061}.
CC   -!- CATALYTIC ACTIVITY: Pyruvate + [dihydrolipoyllysine-residue
CC       acetyltransferase] lipoyllysine = [dihydrolipoyllysine-residue
CC       acetyltransferase] S-acetyldihydrolipoyllysine + CO(2).
CC       {ECO:0000269|PubMed:19081061}.
CC   -!- COFACTOR:
CC       Name=thiamine diphosphate; Xref=ChEBI:CHEBI:58937;
CC         Evidence={ECO:0000269|PubMed:12651851,
CC         ECO:0000269|PubMed:19081061};
CC   -!- SUBUNIT: Heterotetramer of two PDHA1 and two PDHB subunits
CC       (PubMed:12651851, PubMed:17474719, PubMed:19081061). The
CC       heterotetramer interacts with DLAT, and is part of the multimeric
CC       pyruvate dehydrogenase complex that contains multiple copies of
CC       pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase
CC       (DLAT, E2) and lipoamide dehydrogenase (DLD, E3)
CC       (PubMed:14638692). These subunits are bound to an inner core
CC       composed of about 48 DLAT and 12 PDHX molecules (PubMed:14638692).
CC       Interacts with DLAT (PubMed:20160912).
CC       {ECO:0000269|PubMed:12651851, ECO:0000269|PubMed:14638692,
CC       ECO:0000269|PubMed:17474719, ECO:0000269|PubMed:19081061,
CC       ECO:0000269|PubMed:20160912}.
CC   -!- INTERACTION:
CC       P10515:DLAT; NbExp=7; IntAct=EBI-1035872, EBI-2959723;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P11177-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11177-2; Sequence=VSP_012675;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P11177-3; Sequence=VSP_043364;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Pyruvate dehydrogenase E1-beta deficiency (PDHBD)
CC       [MIM:614111]: An enzymatic defect causing primary lactic acidosis
CC       in children. It is associated with a broad clinical spectrum
CC       ranging from fatal lactic acidosis in the newborn to chronic
CC       neurologic dysfunction with structural abnormalities in the
CC       central nervous system without systemic acidosis.
CC       {ECO:0000269|PubMed:15138885}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M34479; AAA36428.1; -; mRNA.
DR   EMBL; M19123; AAA60052.1; ALT_SEQ; mRNA.
DR   EMBL; M54788; AAA60053.1; -; mRNA.
DR   EMBL; M34055; AAA60233.1; -; mRNA.
DR   EMBL; M34056; AAA60054.1; -; mRNA.
DR   EMBL; D90086; BAA14123.1; -; Genomic_DNA.
DR   EMBL; J03576; AAA88097.1; -; mRNA.
DR   EMBL; AL117618; CAB56017.1; -; mRNA.
DR   EMBL; CR541911; CAG46709.1; -; mRNA.
DR   EMBL; AK293153; BAG56698.1; -; mRNA.
DR   EMBL; AK313022; BAG35857.1; -; mRNA.
DR   EMBL; AC135507; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW65371.1; -; Genomic_DNA.
DR   EMBL; BC000439; AAH00439.1; -; mRNA.
DR   EMBL; BC001924; AAH01924.1; -; mRNA.
DR   EMBL; X57778; CAA40924.1; -; mRNA.
DR   CCDS; CCDS2890.1; -. [P11177-1]
DR   CCDS; CCDS54602.1; -. [P11177-3]
DR   CCDS; CCDS82795.1; -. [P11177-2]
DR   PIR; JU0145; DEHUPB.
DR   RefSeq; NP_000916.2; NM_000925.3. [P11177-1]
DR   RefSeq; NP_001166939.1; NM_001173468.1. [P11177-3]
DR   RefSeq; NP_001302465.1; NM_001315536.1. [P11177-2]
DR   UniGene; Hs.161357; -.
DR   PDB; 1NI4; X-ray; 1.95 A; B/D=31-359.
DR   PDB; 2OZL; X-ray; 1.90 A; B/D=32-359.
DR   PDB; 3EXE; X-ray; 1.98 A; B/D/F/H=31-359.
DR   PDB; 3EXF; X-ray; 3.00 A; B/D/F/H=31-359.
DR   PDB; 3EXG; X-ray; 3.01 A; 2/4/6/B/D/F/H/J/L/N/P/R/T/V/X/Z=31-359.
DR   PDB; 3EXH; X-ray; 2.44 A; B/D/F/H=31-359.
DR   PDB; 3EXI; X-ray; 2.20 A; B=31-359.
DR   PDBsum; 1NI4; -.
DR   PDBsum; 2OZL; -.
DR   PDBsum; 3EXE; -.
DR   PDBsum; 3EXF; -.
DR   PDBsum; 3EXG; -.
DR   PDBsum; 3EXH; -.
DR   PDBsum; 3EXI; -.
DR   ProteinModelPortal; P11177; -.
DR   SMR; P11177; -.
DR   BioGrid; 111188; 62.
DR   DIP; DIP-37651N; -.
DR   IntAct; P11177; 24.
DR   MINT; MINT-3007546; -.
DR   STRING; 9606.ENSP00000307241; -.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB00119; Pyruvic acid.
DR   iPTMnet; P11177; -.
DR   PhosphoSitePlus; P11177; -.
DR   SwissPalm; P11177; -.
DR   BioMuta; PDHB; -.
DR   DMDM; 134044259; -.
DR   REPRODUCTION-2DPAGE; IPI00549885; -.
DR   SWISS-2DPAGE; P11177; -.
DR   UCD-2DPAGE; P11177; -.
DR   EPD; P11177; -.
DR   MaxQB; P11177; -.
DR   PaxDb; P11177; -.
DR   PeptideAtlas; P11177; -.
DR   PRIDE; P11177; -.
DR   TopDownProteomics; P11177-1; -. [P11177-1]
DR   DNASU; 5162; -.
DR   Ensembl; ENST00000302746; ENSP00000307241; ENSG00000168291. [P11177-1]
DR   Ensembl; ENST00000383714; ENSP00000373220; ENSG00000168291. [P11177-2]
DR   Ensembl; ENST00000485460; ENSP00000417267; ENSG00000168291. [P11177-3]
DR   GeneID; 5162; -.
DR   KEGG; hsa:5162; -.
DR   UCSC; uc003dkf.4; human. [P11177-1]
DR   CTD; 5162; -.
DR   DisGeNET; 5162; -.
DR   GeneCards; PDHB; -.
DR   HGNC; HGNC:8808; PDHB.
DR   HPA; CAB033794; -.
DR   HPA; HPA036744; -.
DR   HPA; HPA036745; -.
DR   MalaCards; PDHB; -.
DR   MIM; 179060; gene.
DR   MIM; 614111; phenotype.
DR   neXtProt; NX_P11177; -.
DR   OpenTargets; ENSG00000168291; -.
DR   Orphanet; 255138; Pyruvate dehydrogenase E1-beta deficiency.
DR   PharmGKB; PA33152; -.
DR   eggNOG; KOG0524; Eukaryota.
DR   eggNOG; COG0022; LUCA.
DR   GeneTree; ENSGT00530000063423; -.
DR   HOGENOM; HOG000281450; -.
DR   HOVERGEN; HBG000917; -.
DR   InParanoid; P11177; -.
DR   KO; K00162; -.
DR   OMA; RKTHHLV; -.
DR   OrthoDB; EOG091G0D37; -.
DR   PhylomeDB; P11177; -.
DR   TreeFam; TF105674; -.
DR   BioCyc; MetaCyc:HS09727-MONOMER; -.
DR   Reactome; R-HSA-204174; Regulation of pyruvate dehydrogenase (PDH) complex.
DR   Reactome; R-HSA-389661; Glyoxylate metabolism and glycine degradation.
DR   Reactome; R-HSA-5362517; Signaling by Retinoic Acid.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   SABIO-RK; P11177; -.
DR   ChiTaRS; PDHB; human.
DR   EvolutionaryTrace; P11177; -.
DR   GeneWiki; Pyruvate_dehydrogenase_(lipoamide)_beta; -.
DR   GenomeRNAi; 5162; -.
DR   PRO; PR:P11177; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000168291; -.
DR   CleanEx; HS_PDHB; -.
DR   ExpressionAtlas; P11177; baseline and differential.
DR   Genevisible; P11177; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045254; C:pyruvate dehydrogenase complex; IDA:UniProtKB.
DR   GO; GO:0004739; F:pyruvate dehydrogenase (acetyl-transferring) activity; TAS:ProtInc.
DR   GO; GO:0004738; F:pyruvate dehydrogenase activity; IDA:UniProtKB.
DR   GO; GO:0006086; P:acetyl-CoA biosynthetic process from pyruvate; IDA:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0046487; P:glyoxylate metabolic process; TAS:Reactome.
DR   GO; GO:0061732; P:mitochondrial acetyl-CoA biosynthetic process from pyruvate; IC:MGI.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   GO; GO:0010510; P:regulation of acetyl-CoA biosynthetic process from pyruvate; TAS:Reactome.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IDA:UniProtKB.
DR   Gene3D; 3.40.50.920; -; 1.
DR   InterPro; IPR027110; PDHB.
DR   InterPro; IPR029061; THDP-binding.
DR   InterPro; IPR009014; Transketo_C/PFOR_II.
DR   InterPro; IPR005475; Transketolase-like_Pyr-bd.
DR   InterPro; IPR033248; Transketolase_C.
DR   PANTHER; PTHR11624:SF89; PTHR11624:SF89; 1.
DR   Pfam; PF02779; Transket_pyr; 1.
DR   Pfam; PF02780; Transketolase_C; 1.
DR   SMART; SM00861; Transket_pyr; 1.
DR   SUPFAM; SSF52518; SSF52518; 1.
DR   SUPFAM; SSF52922; SSF52922; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Carbohydrate metabolism; Complete proteome; Direct protein sequencing;
KW   Disease mutation; Glucose metabolism; Mitochondrion; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Pyruvate; Reference proteome;
KW   Thiamine pyrophosphate; Transit peptide; Tricarboxylic acid cycle.
FT   TRANSIT       1     30       Mitochondrion.
FT                                {ECO:0000269|PubMed:2295468,
FT                                ECO:0000269|PubMed:7895732}.
FT   CHAIN        31    359       Pyruvate dehydrogenase E1 component
FT                                subunit beta, mitochondrial.
FT                                /FTId=PRO_0000020457.
FT   BINDING      89     89       Thiamine pyrophosphate.
FT                                {ECO:0000269|PubMed:12651851}.
FT   SITE        319    319       Important for interaction with DLAT.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MOD_RES      67     67       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q9D051}.
FT   MOD_RES     354    354       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9D051}.
FT   VAR_SEQ      16     33       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11230166}.
FT                                /FTId=VSP_012675.
FT   VAR_SEQ     135    152       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043364.
FT   VARIANT      31     31       L -> V. {ECO:0000269|PubMed:2376596,
FT                                ECO:0000269|PubMed:3422424}.
FT                                /FTId=VAR_004967.
FT   VARIANT     132    132       Y -> C (in PDHBD; dbSNP:rs28935769).
FT                                {ECO:0000269|PubMed:15138885}.
FT                                /FTId=VAR_030954.
FT   VARIANT     344    344       P -> S (in PDHBD; dbSNP:rs28933391).
FT                                {ECO:0000269|PubMed:15138885}.
FT                                /FTId=VAR_021058.
FT   MUTAGEN     259    259       E->A,Q: Does not affect interaction with
FT                                DLAT. {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     262    262       E->A,Q: Does not affect interaction with
FT                                DLAT. {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     264    264       E->A,Q: Does not affect interaction with
FT                                DLAT. {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     319    319       D->A: Inhibits interaction with DLAT.
FT                                Does not affect pyruvate decarboxylase
FT                                activity. Loss of multienzyme pyruvate
FT                                dehydrogenase complex activity.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     319    319       D->N: Reduces interaction with DLAT.
FT                                Reduces multienzyme pyruvate
FT                                dehydrogenase complex activity. Does not
FT                                affect pyruvate decarboxylase activity.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     359    359       I->A: Reduces pyruvate decarboxylase and
FT                                multienzyme pyruvate dehydrogenase
FT                                complex activity. Does not affect
FT                                interaction with DLAT.
FT                                {ECO:0000269|PubMed:20160912}.
FT   MUTAGEN     359    359       Missing: Reduces pyruvate decarboxylase
FT                                and multienzyme pyruvate dehydrogenase
FT                                complex activity. Does not affect
FT                                interaction with DLAT.
FT                                {ECO:0000269|PubMed:20160912}.
FT   CONFLICT      9     13       RRPLR -> AETPS (in Ref. 5).
FT                                {ECO:0000305}.
FT   CONFLICT     43     43       M -> G (in Ref. 13; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    160    160       Q -> G (in Ref. 5). {ECO:0000305}.
FT   CONFLICT    213    221       PPEAQSKDF -> LRKLSQKIL (in Ref. 5).
FT                                {ECO:0000305}.
FT   CONFLICT    213    213       P -> L (in Ref. 4; AAA88097/BAA14123).
FT                                {ECO:0000305}.
FT   CONFLICT    310    312       MEG -> NGS (in Ref. 5). {ECO:0000305}.
FT   STRAND       32     34       {ECO:0000244|PDB:2OZL}.
FT   HELIX        35     49       {ECO:0000244|PDB:2OZL}.
FT   STRAND       53     57       {ECO:0000244|PDB:2OZL}.
FT   TURN         58     61       {ECO:0000244|PDB:3EXI}.
FT   TURN         69     72       {ECO:0000244|PDB:2OZL}.
FT   HELIX        73     77       {ECO:0000244|PDB:2OZL}.
FT   TURN         79     81       {ECO:0000244|PDB:2OZL}.
FT   STRAND       82     84       {ECO:0000244|PDB:2OZL}.
FT   HELIX        89    101       {ECO:0000244|PDB:2OZL}.
FT   STRAND      105    109       {ECO:0000244|PDB:2OZL}.
FT   HELIX       113    119       {ECO:0000244|PDB:2OZL}.
FT   HELIX       120    124       {ECO:0000244|PDB:2OZL}.
FT   TURN        125    129       {ECO:0000244|PDB:2OZL}.
FT   HELIX       130    133       {ECO:0000244|PDB:2OZL}.
FT   TURN        134    136       {ECO:0000244|PDB:3EXI}.
FT   STRAND      143    147       {ECO:0000244|PDB:2OZL}.
FT   HELIX       156    158       {ECO:0000244|PDB:2OZL}.
FT   HELIX       163    167       {ECO:0000244|PDB:2OZL}.
FT   STRAND      173    175       {ECO:0000244|PDB:2OZL}.
FT   HELIX       180    192       {ECO:0000244|PDB:2OZL}.
FT   STRAND      193    195       {ECO:0000244|PDB:2OZL}.
FT   STRAND      197    201       {ECO:0000244|PDB:2OZL}.
FT   TURN        203    207       {ECO:0000244|PDB:2OZL}.
FT   STRAND      209    211       {ECO:0000244|PDB:2OZL}.
FT   HELIX       214    217       {ECO:0000244|PDB:2OZL}.
FT   STRAND      229    232       {ECO:0000244|PDB:2OZL}.
FT   STRAND      235    241       {ECO:0000244|PDB:2OZL}.
FT   HELIX       245    257       {ECO:0000244|PDB:2OZL}.
FT   TURN        258    260       {ECO:0000244|PDB:2OZL}.
FT   STRAND      263    267       {ECO:0000244|PDB:2OZL}.
FT   STRAND      270    272       {ECO:0000244|PDB:2OZL}.
FT   HELIX       276    286       {ECO:0000244|PDB:2OZL}.
FT   STRAND      289    292       {ECO:0000244|PDB:2OZL}.
FT   HELIX       301    311       {ECO:0000244|PDB:2OZL}.
FT   HELIX       315    317       {ECO:0000244|PDB:2OZL}.
FT   STRAND      323    325       {ECO:0000244|PDB:2OZL}.
FT   STRAND      329    331       {ECO:0000244|PDB:3EXE}.
FT   HELIX       336    340       {ECO:0000244|PDB:2OZL}.
FT   HELIX       346    357       {ECO:0000244|PDB:2OZL}.
SQ   SEQUENCE   359 AA;  39233 MW;  AB459B1259FBDBD3 CRC64;
     MAAVSGLVRR PLREVSGLLK RRFHWTAPAA LQVTVRDAIN QGMDEELERD EKVFLLGEEV
     AQYDGAYKVS RGLWKKYGDK RIIDTPISEM GFAGIAVGAA MAGLRPICEF MTFNFSMQAI
     DQVINSAAKT YYMSGGLQPV PIVFRGPNGA SAGVAAQHSQ CFAAWYGHCP GLKVVSPWNS
     EDAKGLIKSA IRDNNPVVVL ENELMYGVPF EFPPEAQSKD FLIPIGKAKI ERQGTHITVV
     SHSRPVGHCL EAAAVLSKEG VECEVINMRT IRPMDMETIE ASVMKTNHLV TVEGGWPQFG
     VGAEICARIM EGPAFNFLDA PAVRVTGADV PMPYAKILED NSIPQVKDII FAIKKTLNI
//
